N/A
Completed N=43
Micra Accelerometer Sensor Study 2
Bradyarrhythmia
Source: ClinicalTrials.gov NCT02930980 ↗
Enrolled (actual)
43
Serious AEs
0.0%
Results posted
Mar 2019
Primary outcomePrimary: Waveform and Components of Accelerometer Signal — 0.15601; 0.19222; 0.14398 g (unit (g) represent acceleration)
Summary
The purpose of the MASS2 is to characterize accelerometer signals of Micra implantable device during different postures and activities and to understand the source of the sensed motion, in order to test feasibility for future enhancements in device functionalities.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Waveform and Components of Accelerometer Signal |
0.15601; 0.19222; 0.14398 | — |
Eligibility Criteria
Inclusion Criteria
- Subject is ≥ 18 years old
- Subject is implanted with a Micra device
- Subject or witness (if applicable as per local regulation) is able and willing to provide Informed Consent
Exclusion Criteria
- Subject is in atrial fibrillation
- Subject is not able to perform study requirements
Data sourced from ClinicalTrials.gov (NCT02930980). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.